Enerzair Breezhaler 150 mcg/50 mcg/160 mcg Inhalation powder 160 MCG/1 CAP, 150 MCG/1 CAP, 50 MCG/1 CAP Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

enerzair breezhaler 150 mcg/50 mcg/160 mcg inhalation powder 160 mcg/1 cap, 150 mcg/1 cap, 50 mcg/1 cap

شركة مستودع الأدوية الأردني - the jordan drugstore co - mometasone furoate 160 mcg/1 cap, indacaterol 150 mcg/1 cap, glycopyrronium bromide 50 mcg/1 cap - 160 mcg/1 cap, 150 mcg/1 cap, 50 mcg/1 cap

Atectura Breezhaler (Indacaterol Acetate/Mometasone Furoate) 150/80mcg Inhalation Powder Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atectura breezhaler (indacaterol acetate/mometasone furoate) 150/80mcg inhalation powder hard capsules

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

Atectura Breezhaler (Indacaterol Acetate/Mometasone Furoate) 150/160mcg Inhalation Powder Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atectura breezhaler (indacaterol acetate/mometasone furoate) 150/160mcg inhalation powder hard capsules

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

Atectura Breezhaler (Indacaterol Acetate/Mometasone Furoate) 150/320mcg Inhalation Powder Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atectura breezhaler (indacaterol acetate/mometasone furoate) 150/320mcg inhalation powder hard capsules

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

Atectura Breezhaler (Indacaterol AcetateMometasone Furoate) 15080mcg Inhalation Powder Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atectura breezhaler (indacaterol acetatemometasone furoate) 15080mcg inhalation powder hard capsules

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

Atectura Breezhaler (Indacaterol AcetateMometasone Furoate) 150160mcg Inhalation Powder Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atectura breezhaler (indacaterol acetatemometasone furoate) 150160mcg inhalation powder hard capsules

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

Atectura Breezhaler (Indacaterol AcetateMometasone Furoate) 150320mcg Inhalation Powder Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atectura breezhaler (indacaterol acetatemometasone furoate) 150320mcg inhalation powder hard capsules

novartis corporation (malaysia) sdn. bhd. - mometasone furoate; indacaterol acetate -

ONBREZ BREEZHALER 150 MCG Israel - English - Ministry of Health

onbrez breezhaler 150 mcg

novartis israel ltd - indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 150 mcg - indacaterol - maintenance of bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (copd).

Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) European Union - English - EMA (European Medicines Agency)

riarify (previously chf 5993 chiesi farmaceutici s.p.a.)

chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1).

Atectura Breezhaler European Union - English - EMA (European Medicines Agency)

atectura breezhaler

novartis europharm limited  - indacaterol acetate, mometasone furoate - asthma - drugs for obstructive airway diseases, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.